I think it's reasonable for companies to be able to rely on some assumed knowledge that anyone seriously looking to invest, will have gained in their own research. The FDA website covers medical devices and you can google it.
Otherwise all announcements and presentations will be bogged down and you must capture interest and retain it.
It is good however to include indicative timelines for FDA approvals.
But here it seems very likely we are going to partner. They say this outright.
So the timing is something that's going to be undertaken by the new partners.
I think the message has been much more effectively communicated than before. A vast improvement IMO
Ann: AGM CEO Presentation, page-18
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.00 |
Change
0.000(0.00%) |
Mkt cap ! $346.0M | |||
| Open | High | Low | Value | Volume |
| $18.00 | $18.10 | $17.70 | $58.64K | 3.27K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 109 | $18.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.10 | 700 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |